A novel approach to cancer immunotherapy — strategies designed to induce the immune system to attack cancer cells — may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.
A Harvard School of Public Health study has found that new federal standards launched in 2012 that require schools to offer healthier meals have led to more fruit and vegetable consumption. This contradicts criticisms that the new standards have increased food waste.
Researchers at the Broad Institute and Massachusetts General Hospital, both Harvard affiliates, have identified mutations in a gene that can reduce the risk of individuals developing type 2 diabetes. If a drug can be developed that mimics the protective effect of these mutations, it could open up new ways of preventing this devastating disease.
In a small study by Harvard-affiliated Massachusetts General Hospital, increasing the number of calories consumed by patients with amyotrophic lateral sclerosis (ALS) may be a relatively simple way of extending their survival.
Harvard stem cell scientists studying the effect of nitric oxide on liver growth and regeneration appear to have serendipitously discovered a markedly improved treatment for liver damage caused by acetaminophen toxicity.
Toxic chemicals may be triggering recent increases in neurodevelopmental disabilities among children — such as autism, attention-deficit hyperactivity disorder, and dyslexia — according to a new study. The researchers say a new global prevention strategy to control the use of these substances is urgently needed.
Hospital stewardship programs, community education, and legal changes to allow pharmaceutical companies to profit longer from new antibiotics are among reforms that experts suggest to fight drug-resistant bacteria.
The first clinical trial of a drug intended to delay the onset of symptoms of Huntington’s disease (HD) reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most study participants. Neuroimaging also showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic HD.
A landmark study across many cancer types reveals that the universe of cancer mutations is much bigger than previously thought. By analyzing the genomes of thousands of patients’ tumors, a Broad Institute-led research team has discovered enough new cancer genes to expand the list by 25 percent.
The average life expectancy in the United States has fallen behind that of other industrialized nations as the American income gap has widened. Also, particular health habits, including weight control, nutrition, and exercise, clearly influence the effects aging among segments of the U.S. population.
Sign up for daily emails with the latest Harvard news.
A group of Harvard Medical School students is using the viral success of tongue-in-cheek video on the spleen to promote science education, launching a contest for younger students to make organ-themed music videos.
Research by Harvard Stem Cell Institute scientists shows that much lincRNA, which had been generally believed useless, plays an important role in the genome.
For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health (HSPH) investigators in collaboration with Bayer HealthCare.
Though variability is often portrayed as a flaw to be overcome, Harvard researchers now say that, in motor function, it is a key feature of the nervous system that helps promote better or more successful ways to perform a particular action.
“Beige fat” cells found in healthy subcutaneous fat in mice play a critical role in protecting the body against the disease risks of obesity, report Harvard researchers at the Dana-Farber Cancer Institute, who say their study findings may have implications for therapy of obesity-related illness in humans.
HIV antiviral therapy lets infected people live relatively healthy lives for many years, but the virus doesn’t go away completely. If treatment stops, the virus multiplies again from hidden reservoirs in the body. Researchers may have found HIV’s viral hiding place — in a small group of recently identified T cells with stem cell-like properties.
The waterproof, light-activated glue developed by researchers at Harvard-affiliated Brigham and Women’s Hospital and Children’s Hospital Boston and their colleagues at MIT can successfully secure biodegradable patches to seal holes in a beating heart.
Using color-coded labels to mark healthier foods and then displaying them more prominently appears to have prompted customers to make more healthful long-term dining choices in their large hospital cafeteria, according to a report from Harvard-affiliated Massachusetts General Hospital
The idea that the wave of diabetes, heart disease, and cancer breaking over the world is largely the result of wealth and inactivity is not only wrong, it’s counterproductive, says a Harvard research fellow who recently founded a nonprofit organization to fight disease.
Ludwig Cancer Research, on behalf of its founder, Daniel K. Ludwig, has given Harvard Medical School $90 million to spur innovative scientific inquiry and discovery. According to the Ludwig announcement, this new financial support is among the largest private gifts ever for cancer research.